<?xml version="1.0" encoding="UTF-8"?>
<p>Intracranial teratomas, one of Central Nervous System (CNS) non-germinomatous germ cell tumors (NGGCTs), according to the 2016 CNS WHO classifications, account for 0.5% of all intracranial tumors and 2–4% of intracranial tumors in children (
 <xref rid="B1" ref-type="bibr">1</xref>). CNS teratomas commonly originate near the midline area of the brain, especially the pineal gland and suprasellar region, as solitary or multiple lesions (
 <xref rid="B2" ref-type="bibr">2</xref>). Teratomas in the brainstem are rare and may present diagnostic difficulties. Till now, only 4 cases of teratoma in medulla oblongata have been reported: one in adult and 3 pediatric patients (
 <xref rid="B3" ref-type="bibr">3</xref>–
 <xref rid="B5" ref-type="bibr">5</xref>). Surgery resection is essential but challenging. Overall, the outcome of teratoma in medulla oblongata remains poor. Prognosis varies depending on the excision of the tumor, which acts as a space-occupying lesion. Overall, the clinical outcome of teratoma in the medulla oblongata proved to be undesirable.
</p>
